Clinical trials for Cancer in United States

Aromatherapy Inhaler Use for HSCT Distress

Study ID: NCT05302583

Sponsor

Stanford University

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Study ID: NCT04115163

Sponsor

Anne Noonan

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

Study ID: NCT04680377

Sponsor

Jun Zhang, MD, PhD

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients with High Risk Solid Tumors

Study ID: NCT05238792

Sponsor

Children's National Research Institute

A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

Study ID: NCT06157892

Sponsor

Seagen, a wholly owned subsidiary of Pfizer

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

Study ID: NCT05564936

Sponsor

To science

Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy

Study ID: NCT05283564

Sponsor

Stanford University

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Study ID: NCT05848687

Sponsor

Tanja Andrea Gruber

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

Study ID: NCT04333706

Sponsor

University of Southern California

REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)

Study ID: NCT05632809

Sponsor

M.D. Anderson Cancer Center